Similar Articles
371 FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations
372 Study on chronic pancreatitis and pancreatic cancer using MRS and pancreatic juice samples
373 SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer
374 Survivin and pancreatic cancer
375 CT diagnosis of recurrence after pancreatic cancer: Is there a pattern?
376 Effects of CPG ODN on biological behavior of PANC-1 and expression of TLR9 in pancreatic cancer
377 Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis
378 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer
379 Staining for p53 and Ki-67 increases the sensitivity of EUS-FNA to detect pancreatic malignancy
380 Neoadjuvant treatment for resectable pancreatic cancer: Time for phase III testing?
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA